| αIL-17A | anti-Interleukin-17A antibody |
| A1C | Hemoglobin glycated average blood sugar |
| ANOVA | Analysis of variance |
| Act1 | adaptor molecule 1 |
| BCA | Bicinchoninic acid |
| BW | Body weight |
| CU | Chemiluminescent unit |
| DB | Diabetic |
| db/db | Leprdb mice |
| ELISA | Enzyme-linked immunosorbent assay |
| ERK5 | Extracellular signal receptor kinase 5 |
| FADD | Fas-associated death domain |
| FBG | Fasted blood glucose |
| FDA | Food and drug administration |
| Het | Heterozygous |
| IgG1 | Immunoglobulin G1 |
| IL-1β | Interleukin-1 beta |
| IL-6 | Interleukin-6 |
| IL-17A | Interleukin-17A |
| IL17R | Interleukin-17A receptor |
| IL-17RA | Interleukin-17A receptor A |
| IP | Intraperitoneal |
| kDa | Kilo-Dalton |
| MW | Molecular weight |
| ND | Non-diabetic |
| NFκB | Nuclear factor kappa B |
| RORγt | Retinoic acid-related orphan receptor-gamma t |
| SD | Standard deviation |
| SEM | Standard error of the mean |
| STZ | Streptozotocin |
| Th17 | T helper 17 |
| TNF-α | Tumor necrosis factor alpha |
| TRAF | TNF receptor associated factor |
| TRAF6 | TNF receptor associated factor 6 |
| VEGF | Vascular endothelial growth factor |
| ZO-1 | Zonula occludens-1 |